• Thumbnail for Bristol Myers Squibb
    The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton...
    97 KB (7,689 words) - 17:19, 16 October 2024
  • Thumbnail for The Bristol-Myers Squibb Children's Hospital
    The Bristol-Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital (BMSCH) is a freestanding, 68-bed pediatric acute care children's...
    37 KB (2,630 words) - 18:49, 26 August 2024
  • Between 1977 and 2006, the Bristol-Myers Squibb Foundation presented annual awards of US$50,000 to scientists for distinguished achievements in fields...
    9 KB (124 words) - 00:50, 5 February 2024
  • Thumbnail for John Ripley Myers
    as Bristol-Myers Squibb. Bristol-Myers Squibb is one of the largest pharmaceutical companies in the world. Myers' stepmother, Mary Ware Hewitt Myers (1848–1942)...
    7 KB (721 words) - 03:50, 21 June 2023
  • "Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023" (PDF). "Bristol Myers Squibb Q4 2022 Results" (PDF). "Bristol Myers...
    62 KB (2,735 words) - 16:33, 29 August 2024
  • William McLaren Bristol (28 July 1860 – 1935) was one of the two co-founders of Bristol-Myers, now part of Bristol-Myers Squibb. Myers and Bristol founded the...
    2 KB (158 words) - 06:30, 24 May 2022
  • growth was delayed by approximately 4.1 months. In September 2001, Bristol-Myers Squibb committed $2 billion (including a $1 billion up-front cash payment)...
    20 KB (2,186 words) - 04:10, 19 September 2024
  • Thumbnail for Xanomeline/trospium chloride
    Bristol-Myers Squibb. Xanomeline/trospium chloride was approved for medical use in the United States in September 2024. In 2024, Bristol Myers Squibb...
    16 KB (1,436 words) - 05:19, 17 October 2024
  • Bristol-Myers Squibb Co. v. Superior Court of California, San Francisco County, 582 U.S. ___ (2017), was a United States Supreme Court case in which the...
    10 KB (1,108 words) - 19:26, 7 September 2024
  • treatment. In June 2022, Owkin entered a strategic alliance with Bristol-Myers Squibb to help them design potentially more precise and efficient clinical...
    21 KB (1,806 words) - 09:58, 6 September 2024
  • Thumbnail for Thalidomide
    Thalidomide (category Drugs developed by Bristol Myers Squibb)
    Thalidomide, sold under the brand names Contergan and Thalomid among others, is an oral medication used to treat a number of cancers (e.g., multiple myeloma)...
    76 KB (7,430 words) - 09:47, 9 October 2024
  • Thumbnail for Excedrin (brand)
    contains paracetamol, aspirin and caffeine. It was manufactured by Bristol-Myers Squibb until it was purchased by Novartis in July 2005 along with other...
    14 KB (1,370 words) - 22:49, 11 October 2024
  • Thumbnail for Deucravacitinib
    Deucravacitinib (category Drugs developed by Bristol Myers Squibb)
    2 (TYK2) inhibitor and it is taken by mouth. It was developed by Bristol Myers Squibb. Deucravacitinib was approved for medical use in the United States...
    12 KB (697 words) - 09:25, 1 July 2024
  • equity investment agreement with Bristol-Myers Squibb. Under the terms of the agreement, Bristol Bristol-Myers Squibb will supply Opdivo®, its PD-1 inhibitor...
    18 KB (1,956 words) - 13:48, 9 May 2024
  • Thumbnail for Apixaban
    Apixaban (category Drugs developed by Bristol Myers Squibb)
    medications. It is a direct factor Xa inhibitor. In 2007, Pfizer and Bristol-Myers Squibb began development of apixaban as an anticoagulant. Apixaban was approved...
    25 KB (2,069 words) - 16:34, 23 September 2024
  • Thumbnail for Celgene
    Celgene (category Bristol Myers Squibb)
    Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb (BMS). Celgene was originally a unit of Celanese. In 1986, Celanese...
    32 KB (2,807 words) - 19:07, 12 September 2024
  • Thumbnail for E. R. Squibb
    pharmaceutics who founded E. R. Squibb and Sons, which eventually became part of the modern pharmaceutical giant Bristol-Myers Squibb. Squibb was born in Wilmington...
    11 KB (1,134 words) - 00:08, 10 October 2024
  • Thumbnail for Robert Wood Johnson University Hospital
    transplantation, cancer care, and women's and children's care including The Bristol-Myers Squibb Children's Hospital at RWJUH, which has several areas of pediatric...
    37 KB (3,205 words) - 07:59, 21 February 2023
  • Thumbnail for John C. Martin (businessman)
    from 1978 to 1984. Martin was director of antiviral chemistry at Bristol-Myers Squibb from 1984 to 1990. Martin joined the American biotechnology company...
    15 KB (1,443 words) - 23:49, 7 October 2024
  • Thumbnail for Cefepime
    found no mortality difference. Cefepime was patented in 1982 by Bristol-Myers Squibb and approved for medical use in 1994. It is available as a generic...
    8 KB (600 words) - 20:51, 10 October 2024
  • Thumbnail for Mavacamten
    Mavacamten (category Drugs developed by Bristol Myers Squibb)
    myosin inhibitor. It was developed by MyoKardia, a subsidiary of Bristol Myers Squibb. In clinical studies, mavacamten has demonstrated significant efficacy...
    19 KB (1,217 words) - 01:27, 28 March 2024
  • Nivolumab/relatlimab (category Drugs developed by Bristol Myers Squibb)
    treatment of melanoma. The applicant for this medicinal product is Bristol-Myers Squibb Pharma EEIG. Opdualag was approved for medical use in the European...
    13 KB (761 words) - 04:27, 31 March 2024
  • Medarex (category Drugs developed by Bristol Myers Squibb)
    Milpitas and Sunnyvale, California. In 2009, Medarex was purchased by Bristol Myers Squibb. Medarex developed monoclonal antibodies to CTLA-4 and PD-1, which...
    6 KB (611 words) - 04:22, 3 October 2024
  • Thumbnail for Milvexian
    prevention of blood clots in patients undergoing surgery. In 2018–2023, Bristol-Myers Squibb studied milvexian for the prevention of stroke. Perera V, Wang Z...
    4 KB (173 words) - 05:43, 28 June 2023
  • Thumbnail for Captopril
    Captopril (category Drugs developed by Bristol Myers Squibb)
    drug company E.R. Squibb & Sons Pharmaceuticals (now Bristol-Myers Squibb): Miguel Ondetti, Bernard Rubin, and David Cushman. Squibb filed for U.S. patent...
    22 KB (2,239 words) - 14:19, 20 September 2024
  • Thumbnail for Saxagliptin
    Saxagliptin (category Drugs developed by Bristol Myers Squibb)
    class. Early development was solely by Bristol-Myers Squibb; in 2007 AstraZeneca joined with Bristol-Myers Squibb to co-develop the final compound and collaborate...
    20 KB (1,961 words) - 20:50, 5 April 2024
  • Thumbnail for Cancer immunotherapy
    Princeton, New Jersey: Bristol-Myers Squibb Company. Archived from the original (PDF) on 8 December 2015. "Bristol Myers Squibb Reports Primary Results...
    92 KB (12,517 words) - 05:38, 1 October 2024
  • Laboratory Braun – B. Braun Melsungen (Medical) Ltd Bristol-Myers SquibbBristol-Myers Squibb Pharmaceuticals Ltd Celltech – UCB Pharma Ltd Cephalon...
    8 KB (815 words) - 00:56, 9 July 2024
  • Mirati Therapeutics (category Bristol Myers Squibb)
    company that focuses on the development of cancer therapeutics. Bristol Myers Squibb acquired the company in January 2024. Mirati Therapeutics works largely...
    5 KB (354 words) - 01:43, 28 January 2024
  • Thumbnail for Clopidogrel
    Clopidogrel (category Drugs developed by Bristol Myers Squibb)
    of a patent infringement case brought by Bristol-Myers Squibb. The court ruled that Bristol-Myers Squibb's patent was valid and provided protection until...
    44 KB (3,709 words) - 08:54, 8 September 2024